Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jos Crush

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
British Journal of Anaesthesia|March 20, 2023
The pitfalls of labelling opioids as weak or strong. Response to Br J Anaesth 2022; 129:e150-e153Jos Crush, Nicholas Levy, Roger D Knaggs, et al.
British Journal of Anaesthesia|April 10, 2022
Misappropriation of the 1986 WHO analgesic ladder: the pitfalls of labelling opioids as weak or strongJos Crush, Nicholas Levy, Roger D Knaggs, et al.
Frontiers in Cell and Developmental Biology|July 1, 2021
Bioactive Glass: Methods for Assessing Angiogenesis and OsteogenesisJos Crush, Ali Hussain, K T M Seah, et al.
Archives of Orthopaedic and Trauma Surgery|September 8, 2021
Sequential low molecular weight heparin and rivaroxaban for venous thromboprophylaxis in pelvic and acetabular traumaJos Crush, Matthew Seah, Daud Chou, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
British Journal of Anaesthesia|March 20, 2023
The pitfalls of labelling opioids as weak or strong. Response to Br J Anaesth 2022; 129:e150-e153Jos Crush, Nicholas Levy, Roger D Knaggs, et al.
British Journal of Anaesthesia|April 10, 2022
Misappropriation of the 1986 WHO analgesic ladder: the pitfalls of labelling opioids as weak or strongJos Crush, Nicholas Levy, Roger D Knaggs, et al.
Frontiers in Cell and Developmental Biology|July 1, 2021
Bioactive Glass: Methods for Assessing Angiogenesis and OsteogenesisJos Crush, Ali Hussain, K T M Seah, et al.
Archives of Orthopaedic and Trauma Surgery|September 8, 2021
Sequential low molecular weight heparin and rivaroxaban for venous thromboprophylaxis in pelvic and acetabular traumaJos Crush, Matthew Seah, Daud Chou, et al.
Pageof 1